Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

6 results about "Ophthalmic solutions" patented technology

Tobramycin Ophthalmic Solution USP, 0.3% is a topical antibiotic indicated in the treatment of external infections of the eye and its adnexa caused by susceptible bacteria.

Bacteria-blocking eyedrop bottle

ActiveCN224039624UPharmaceutical containersMedical packagingOphthalmic solutionsLiquid storage
The utility model belongs to the technical field of medicine packaging bottles, and particularly relates to a bacteria-blocking eyedrop bottle. Comprising a liquid storage container, a liquid outlet valve, a dripping nozzle and a gland, the liquid outlet valve is arranged at one end of the liquid storage container and comprises a fixing seat and a valve rod located on a top plate of the fixing seat, and a first liquid outlet is formed in the top plate; the gland is connected to one end of the liquid outlet container and covers the liquid outlet valve; the drip nozzle comprises a drip nozzle part and an elastic piece which is located at the lower end of the drip nozzle part and can elastically deform, the drip nozzle part covers the valve rod, the upper end of the drip nozzle part extends out of the gland, the elastic piece is located between the gland and the top plate, and a second liquid outlet is formed in the top of the drip nozzle part. A liquid outlet channel is formed between the valve rod and the drip nozzle part and between the elastic sheet and the top plate, and the top of the valve rod blocks the second liquid outlet in a normal pressure state; bacteria blocking is achieved in a physical mode, and safety and reliability are achieved.
Owner:ZHEJIANG LINRUN PHARM PACKAGING CO LTD

Suspension containing heterocyclidene acetamide derivative

The present disclosure provides suspendable ophthalmic solutions with excellent redispersibility. The present disclosure provides an aqueous suspension agent comprising (E)-2-(7-trifluoromethylchroman-4-ylidene)-N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide or a pharmaceutically acceptable salt or solvate thereof, a cellulosic polymer, and a nonionic surfactant.
Owner:SENJU PHARMA CO LTD +1

Medicine dripping device for ophthalmology department

ActiveCN224235634UEye treatmentMedicineOphthalmic solutions
The utility model provides a medicine dripping device for the ophthalmology department, and belongs to the technical field of medicine dripping devices. Comprising a positioning box and an eyeshade installed at the bottom end of the positioning box, a storage bin is formed in the top end of the positioning box, sliding grooves are formed in the two ends of the positioning box, a medicine storage bag is fixedly embedded in the bottom end of the positioning box, a push plate is slidably inserted into the top end of the positioning box, and clamping grooves are formed in the two sides of the inner wall of each sliding groove; sliding parts embedded in the sliding grooves are fixed to the two ends of the push plate, and clamping plates are inserted into the clamping grooves in a damping mode. The pushing plate is pushed by the extruding plate to move downwards to extrude the medicine storage bag, the sliding parts at the two ends of the pushing plate abut against the clamping plate in the extruding process, the extruding and moving stroke of the pushing plate is controlled by adjusting the position of the clamping plate, and therefore the extruding amount of liquid medicine is accurately controlled, and the situation that too much liquid medicine is extruded, and waste of eye drops is caused is avoided.
Owner:胡晓涵

Suspension containing heterocyclidene acetamide derivative

ActiveUS12564553B2Organic active ingredientsSenses disorderOphthalmic solutionsPharmacology
The present disclosure provides suspendable ophthalmic solutions with excellent redispersibility. The present disclosure provides an aqueous suspension agent comprising (E)-2-(7-trifluoromethylchroman-4-ylidene)-N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide or a pharmaceutically acceptable salt or solvate thereof, a cellulosic polymer, and a nonionic surfactant.
Owner:SENJU PHARMA CO LTD +1

Preservative-free pharmaceutical compositions for ophthalmic administration

UndeterminedES3075659T3Pharmacy medicinePreservative
The present invention relates to a preservative-free aqueous solution in the form of eye drops packaged in a container that ensures product stability, an ideal drop volume and less variability in drop volume, as well as providing efficient dosing.
Owner:NTC SRL (100 00)

Ophthalmic solution adding rack

The utility model discloses an eye drop medicine adding frame, including frame, have the cavity, the baffle that can fix eye drop bottle is equipped in the cavity, the baffle has the bayonet for the neck of eye drop bottle carding, fixed element, be located in the lateral wall of cavity, push and resist eye drop bottle and lean on the baffle, add liquid element, slidingly set up in the frame, including sliding limit piece, communicating pipe spare and needle guide piece, needle guide piece is equipped in one end of communicating pipe spare, the other end of communicating pipe spare can approach or be far from the bottle mouth of eye drop bottle, the syringe needle passes through the passage in the inside of communicating pipe spare by needle guide piece, enters eye drop bottle through the bottle mouth of eye drop bottle, and sliding limit piece restricts the sliding distance of adding liquid subassembly. The utility model can not directly hold eye drop bottle, and simultaneously needle guide piece guides the syringe needle and inserts eye drop bottle, avoids the syringe needle and stabs hand, and also can accurate and stab into eye drop bottle and add medicine.
Owner:XIAMEN EYE CENTER OF XIAMEN UNIVERSITY CO LTD